|
|||
|
The Authors Reply: Reply on “Evidence Is Enough?: A Systematic Review and Network Meta-Analysis of the Efficacy of Tamsulosin 0.2 mg and Tamsulosin 0.4 mg as an Initial Therapeutic Dose in Asian Benign Prostatic Hyperplasia Patients”
Su Jin Kim, In-Soo Shin, Sung-Jong Eun, Taeg-Keun Whangbo, Jin Wook Kim, Young Sam Cho, Joon Chul Kim
Int Neurourol J. 2017;21(3):231-232. Published online 2017 Sep 12
DOI: https://doi.org/10.5213/inj.1734986.493 |
|||
|
Citations to this article as recorded by  Efficacy of tamsulosin 0.4 mg for the treatment in male with the international Prostate Symptom Score ≥ 20 compared with tamsulosin 0.2 mg
Yu Seob Shin, Jae Heon Kim, Zhao Luo, Lin Chuan, Sung Chul Kam
Prostate International.2025;[Epub] CrossRef
|
